The Probe - Proudly serving the dental profession for over 60 years

Early detection in 15 minutes or less

Featured Products Promotional Features

  Posted by: Dental Design      20th November 2023

All too-often, oral cancer is detected in the late stages. This can make treatment difficult, and heavily impact patients’ quality of life. When detected in stages I and II, the chances of survival are doubled.

As such, routine screening for oral cancer is essential and the BeVigilant™ OraFusion™ System from Vigilant Biosciences® produces a simple and accurate risk assessment to aid in early detection.

The non-invasive tool analyses saliva and, in 15 minutes or less, produces a report of either low, moderate, or elevated risk levels associated with oral cancer, to assist dentists in their decision making.

For more information about what could be a truly life-changing, pre-diagnostic test, please contact the team at Vigilant Biosciences® for a demo.

For more information, please visit or email

Join our
Mailing List

Sign up to our newsletter and keep up to date on the latest happenings in the dental market.

Sign up today